Results for tag: "Erythropoiesis Stimulating Agent"

Erythropoiesis Stimulating Agents (ESAs) are a class of drugs used to treat anemia, a condition in which the body does not produce enough red blood cells. ESAs stimulate the production of red blood cells in the bone marrow, increasing the amount of oxygen-carrying hemoglobin in the blood. ESAs are used to treat anemia caused by chemotherapy, chronic kidney disease, and other conditions. They are also used to reduce the need for blood transfusions in certain patients. ESAs are a major component of the hematological drugs market, which includes drugs used to treat blood-related diseases and disorders. The market is driven by the increasing prevalence of anemia and other blood-related disorders, as well as the development of new drugs and treatments. Some companies in the ESA market include Amgen, Johnson & Johnson, Roche, Novartis, and Pfizer. Show Less Read more